← Open Payments lookup

DAVID ALABI: Open Payments

NPI 1942645544 · NEWARK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,026 in 64 payments from 8 companies in 2025. Trend: 2023 $741 · 2024 $886 · 2025 $1,026

Food & beverage: $915Education: $111
CompanyPaymentsAmount
Alkermes, Inc.17$273
ABBVIE INC.21$208
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$195
E.R. Squibb & Sons, L.L.C.14$141
Teva Pharmaceuticals USA, Inc.2$130
Braeburn Inc.3$46
Neurocrine BioSciences, Inc.1$17
Vanda Pharmaceuticals Inc.1$16

Products named: ARISTADA, VRAYLAR, CAPLYTA, COBENFY, BRIXADI, AUSTEDO XR, INGREZZA, FANAPT.

Industry payments across NJ — which companies pay providers there.